Medicine and Dentistry
Myositis
99%
Inclusion Body Myositis
29%
Diseases
23%
Dermatomyositis
20%
Rheumatic Disease
19%
Polymyositis
15%
Autoantibodies
14%
Human Leukocyte Antigen
10%
Autoimmune Disease
10%
Myopathy
8%
Genetic Risk Factor
8%
Skeletal Muscle
8%
Diagnostic Error
8%
Disease Activity
8%
Autoimmune Rheumatic Disease
7%
Bimagrumab
7%
Clinical Study
6%
Malignant Neoplasm
6%
Genetic Background
6%
Zilucoplan
6%
5' Nucleotidase
6%
Positron Emission Tomography
6%
Allele
6%
Amyloid
6%
Pediatric Rheumatology
6%
Cyclizine
6%
Florbetapir (18F)
6%
Placebo-Controlled Study
6%
COVID-19 Vaccination
6%
Troponin
6%
Cell Transplantation
6%
Vaccine Hesitancy
6%
Genotype
6%
Fibrinogen
6%
Cardiac Troponin
6%
Limb Girdle Muscular Dystrophy
6%
Diagnosis
5%
Immunology and Microbiology
Myositis
100%
Autoantibodies
44%
Autoimmune Disease
19%
Dermatomyositis
19%
Polymyositis
18%
Inclusion Body Myositis
15%
Vaccination Policy
12%
Genetic Background
12%
Vaccine Efficacy
12%
COVID-19
12%
Genetic Risk
10%
Prevalence
10%
Human Leukocyte Antigen
10%
HLA DRB1 Antigen
8%
Allele
7%
Rheumatic Disease
7%
Immunoprecipitation
7%
Inflammatory Arthritis
7%
Autoimmune Rheumatic Disease
6%
Genotype
6%
Zilucoplan
6%
Initiation Factor 3
6%
Protein Protein Interaction
6%
Scleroderma
6%
Autoantigen
6%
5' Nucleotidase
6%
Pharmacology, Toxicology and Pharmaceutical Science
Myositis
50%
Vaccination Policy
18%
Autoimmune Disease
18%
Adverse Event
16%
Rheumatic Disease
11%
Disease Activity
10%
Troponin I
9%
Glucocorticoid
8%
Inclusion Body Myositis
7%
Dermatomyositis
7%
Infection
7%
Zilucoplan
6%
Troponin
6%
Rheumatoid Arthritis
6%
Myopathy
6%
Systemic Lupus Erythematosus
6%
SARS Coronavirus
6%
Fibrinogen
6%
Vaccine
6%
Statin (Protein)
6%
Malignant Neoplasm
6%
Genetic Risk
5%
Disease
5%